Analgesic and antibutyrylcholinestrasic activities of the venom prepared from the Mediterranean jellyfish Pelagia noctiluca (Forsskal, 1775) by Yosra Ayed et al.
Ayed et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:15
http://www.ann-clinmicrob.com/content/11/1/15RESEARCH Open AccessAnalgesic and antibutyrylcholinestrasic activities
of the venom prepared from the Mediterranean
jellyfish Pelagia noctiluca (Forsskal, 1775)
Yosra Ayed1, Afef Dellai2, Hedi Ben Mansour2, Hassen Bacha1,3* and Salwa Abid1Abstract
Background: Toxins derived from jellyfishes have been exploited as a model for the development of new drug
promising applications to treat neurodegenerative diseases. The present work is aimed to evaluate the acute
toxicity of crude venom of Pelagia noctiluca and then to screen the analgesic and antibutyrylcholinestrasic
(anti-BuChE) activities of the crude venom and its fractions.
Methods: Sephadex G75 gel was used to separate crude venom of Pelagia noctiluca, which led to some fractions.
In addition, in vivo analgesic and in vitro plasma antibutyrylcholinestrasic activities were carried out with Pelagia
crude venom and its fractions respectively.
Results: The crude venom and its fractions displayed analgesic and anti-BuChE activities at different doses without
inducing acute toxicity. Fraction 2 possesses the highest analgesic and antibutyrylcholinestrasic properties. The
crude venom and fraction 1 had shown to possess less significant inhibitory activity against analgesic and
antibutyrylcholinestrasic models.
Conclusions: Based on this study, the crude venom of Pelagia noctiluca is found to be a useful tool for probing
pharmacological activity. The purification and the determination of chemical structures of compounds of active
fractions of the venom are under investigation.
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Cnidarians are the largest phylum of generally toxic ani-
mals. Their toxins and venoms have not received as
much scientific attention as those of many terrestrial
(snakes, scorpions, spiders, etc.) and some marine ani-
mals (i.e. cone snails) [1].
The jellyfish, Pelagia noctiluca (P. noctiluca) [2] is a
cnidarian of the class Scyphozoa, the order Semaesto-
meae, and the family Pelagiidae. It is widely distributed
in different parts of the Mediterranean Sea [3-5] and in
the Atlantic Ocean [6]. As a member of the phylum* Correspondence: hassen-bacha@fmdm.rnu.tn
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reproduction in any medium, provided the orCnidaria, their main characteristic is the specialized cells
(cnidocytes) harbouring cnidocysts. Cnidocysts, or
nematocysts, contain a complex mixture of highly active
and structurally diverse toxins. The cnidocyst capsules
are discharged as a response to adequate chemical and
mechanical stimuli elicited by prey organisms [7].
The venom of P. noctiluca is of protein nature and
contains peptides. It is antigenic and possesses dermone-
crotic and hemolytic properties [8]; Cytolytic and neuro-
toxic effects have also been shown by several biological
assays [9-12].
Since 1960, Scientists have studied on the biochemis-
try, pharmacology and toxicology of jellyfish venom and
most of them have tried to extract its active components
as a new natural source of drugs. There are several
reports on the antimicrobial activities of the jellyfish
extracts, which can afford design of new antibiotics with
broad-spectrum antimicrobial activity. Ovchinnikova ettd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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termed aurelin, from a scyphoid jellyfish Aurelia aurita.
This Anti-microbial peptide exhibited activity against
Gram positive and Gram-negative bacteria [13]. Than-
garaj et al [14] have studied the antimicrobial activity of
the crude extract of Stichodactyla gigantea and Sticho-
dactyla mertensii. The two sea anemone extracts exhib-
ited significant activity against all bacterial strains.
Williams et al [15] have reported that the tissue extract
of Stichodactyla haddoni showed highly antimicrobial
activity. Synthetic amino-terminal peptides from the sea
anemone Stychodactyla helianthus have shown cytolytic
activity to human erythrocytes and antibacterial activity
against Escherichia coli and Staphylococcus aureus [16].
It was also reported that jellyfish venom could have
promising applications in cardiovascular medicine [17].
So, it is useful to study jellyfish venom for the sake of
the human health. Some experiments in rats showed
that jellyfish can be used to cure arthritis, back pain and
to remedy fatigue [18].
In this regard, our objective in this study was to estab-
lish a procedure for extraction of P. noctiluca crude
venom, to evaluate the acute toxicity, then, to screen the




Lysine acetylsalicylate (ASL) was obtained from Sanofi
Winthrop Pharmaceuticals (Morrisville, PA, USA).
Acetic acid (glacial) was obtained from Sigma Chemical
Co. (St. Louis, MO, USA). Butyrylthiocholine iodide was
purchased from Quimica Clinica Aplicada S.A.
(Amposta, Spain). All other chemicals used were of ana-
lytical grade.
Preparation of nematocysts
Specimens of P. noctiluca were collected from the beach
of Monastir, Tunisia, in May 2010, and were identified
by Professor Mohamed Nejib Daly Yahia from Faculty of
Sciences of Bizerte, (Bizerte, Tunisia). The tentacles were
excised manually from living specimens as soon as pos-
sible after capture and were then immediately frozen at
−20°C.
The nematocysts isolation method has been previously
described by Arillo et al [19]. Tentacles were submerged
in distilled water for 5 h at 4°C. The ratio of organic tis-
sue to distilled water was approximately 1:5. After a
complete detachment of the epidermis the tissue was
removed from the suspension containing both epidermis
and undischarged nematocysts deriving from the os-
motic rupture of nematocysts. The nematocysts,
attached to the epidermal tissue, were separated by stir-
ring. The nematocysts suspension was repeatedly washedin distilled water and filtered through plankton nets
(100, 60 and 40 μm mesh, respectively) to remove most
of the tissue debris, and then centrifuged at 4°C (ALC
PK 120R, 4000g for 5min). The content, purity and in-
tegrity of nematocysts (cnidocysts) were controlled
microscopically, and the concentrate nematocysts were
stored at −80°C until further use [20].
Nematocysts lysis and protein extraction
Crude venom was extracted by sonication on ice (Sono-
plus, 70mHz, 30 times, 20s) of nematocysts as described
by Marino et al [20]. After sonication, the suspension
was centrifuged at 11,000 rpm for 5 min at 4°C. The
supernatant was carefully removed, filtered and
lyophilized.
Protein determination
The protein content of the crude venom was determined
according to the Bradford method (BioRad Labs,
Hercules, CA) [21]. In the following, all mention of
“venom and fractions concentrations” refers to protein
concentration expressed in units of μg ml-1.
SDS-PAGE
Protein species were observed by polyacrylamide gel
electrophoresis (SDS-PAGE) as described previously
[22]. Jellyfish crude venom protein (200 μg) were diluted
(1:1) with sample buffer (50 mM Tris pH 6.8, 2% SDS,
20% glycerol, 2% 2-mercaptoethanol and 0.04% bromo-
phenol blue) and were then boiled for 3 min. Running
gels of 5% acrylamide and stacking gels of 12% acryl-
amide were used. The gels were stained with Coomassie
R-250. The molecular size marker, 6–170 kDa (protein
standards, Invitrogen, CA, USA), was run parallel with
crude venom sample for molecular weight estimation.
Size exclusion chromatography
About 300 mg of crude venom of P. noctiluca was dis-
solved in filtered–degassed double-distilled water. After
centrifugation at 17 000 g for 15 min at 4°C, the super-
natant was loaded on Sephadex G-75 gel-filtration chro-
matography columns (2.6 x 100 cm; Pharmacia),
previously equilibrated with 200 mM ammonium acet-
ate, pH 6.8 and eluted under the same conditions. The
flow rate was 3 ml/min using a Bio-Rad 2110 fraction
collector and the elution of the proteins was monitored
at 280 nm by an ultraviolet detector.
Animals
Swiss albino mice (weighing 18–25 g) of both sexes were
obtained from Pasteur institute (Tunis, Tunisia). They
were housed in polypropylene cages and were left for 1
week under constant conditions of temperature (22 ± 2°
C) and a light/dark cycle of 12 h/12 h. Animals had free
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Housing conditions and in vivo experiments were
approved according to the guidelines established by the
European Union on Animal Care (CFE Council (86/
609)). The mice were used for the acute toxicity testing
and for the analgesic investigation. Animals were divided
into drug-treated ‘test’ and saline-treated ‘control’ groups
of six or eight animals per group.
Acute toxicity
For acute toxicity, mice were divided into groups of
eight animals each. One group served as a control and
received 0.9% NaCl alone (10 ml/kg) given intraperitone-
ally (i.p.), while the remaining groups were treated with
increasing doses of P. noctiluca venom: 1, 5, 10, 20, 30,
40 and 50 mg/kg (i.p.), respectively. The mortality rate
within a 48 h period was determined and the LD50 (the
amount required to kill 50% of animals) was estimated
according to the method described by Miller and Tainter
[23]. According to the results of acute toxicity test, doses
were chosen for pharmacological evaluations. After the
last observation the mice were killed and the liver, lungs,
heart, spleen and kidneys were withdrawn and stocked
for next evaluations.
Analgesic activity
Analgesic activity was performed according to the
method of Koster et al [24] and assessed by the acetic
acid abdominal constriction test (writhing test), a chem-
ical visceral pain model. Swiss albino mice were selected
1 day prior to each test and were divided into groups of
six mice each. One group served as the control and was
pretreated under cutaneously with 10 ml/kg of saline.
Another group was pretreated with the reference drug,
acetyl salicylate of lysine (ASL), 200 mg/kg, by the same
route. The remaining groups were injected intraperito-
neally with 10 ml/kg of 1% acetic acid solution 30 min
after the administration of the crude venom of P. nocti-
luca and its two fractions at the doses of 1 and 2 mg/kg
b.w. (body weight); after acetic acid administration, the
number of writhes was counted during 30 min. Antino-
ciceptive activity was expressed as inhibition percent of
the usual number of writhes observed in control ani-
mals. The percentages of inhibition were calculated
according to the following formula: % inhibition = ((
number of writhes)control − (number of writhes)treated
group) × 100/(number of writhes)control.
In vitro Butyrylcholinesterase inhibition assay
Human plasma preparation
Human blood from anonymous healthy male subject (27
years) was provided by the Hospital of Monastir in Tu-
nisia. Blood was collected in EDTA treated (1 mg/ml)
glass tubes, the red blood cells were eliminated bycentrifugation at 2000 g for 10 min, the plasma (super-
natant) was then recuperated and diluted (1/200) with
50 mM phosphate buffer (pH= 7.4). Plasma was used
immediately for studying butyrylcholinesterase activity
or conserved at 2-8°C (stable for 7 days).Butyrylcholinesterase inhibition assay
Butyrylcholinesterase (BuChE) inhibiting activity was
measured by the spectrophotometric method previously
reported by Ellman et al [25], modified by Ortega et al
[26] and adapted according to our experimental condi-
tions. Butyrylthiocholine iodide was used as substrate to
assay butyrylcholinesterase activity. In order to calculate
the activity of the obtained butyrylcholinesterase, the fol-
lowing procedure was employed: 1.5 ml of phosphate
buffer 50 mM pH=7.2, containing 0.26 mM of 5,5’-
dithiobis-2- nitrobenzoic acid (DTNB), 10 μl of human
plasma and 10 μl of the crude venom of P. noctiluca and
the tested fractions (1, 10 and 100 μg/ml as final concen-
trations) were placed in a microcuvette, which was incu-
bated for 15 min at 30°C. The hydrolysis of
butyrylthiocholine was monitored by the formation of
yellow 5-thio-2-nitrobenzoate anions resulting from the
reaction of DTNB with the thiocholine released by the
enzymatic hydrolysis of butyrylthiocholine. Absorbance
was measured using an M350 double Beam UV–VIS
spectrophotometer « Camespec » at 405 nm, and the
reading was repeated during 75 s at intervals of 30 s to
verify the linearity of the reaction. The enzymatic activity
was calculated using the absorption coefficient 23460
and according to the relation:
Enzymatic activity UI international unitsð Þ=lð Þ
¼ 23460 DO405nmt0s DO405nmt75sð Þ:
The percentage (%) of inhibition of BuChE activity was
calculated as follows: (E – S)/E × 100. Where E is the ac-
tivity of the enzyme without test compound (in our case
E = 9 000 UI/l) and S is the activity of enzyme with test
compound.
IC50 (concentrations of test compounds that inhibited
the hydrolysis of substrate (butyrylthiocholine) by 50%)
values were calculated from dose-inhibition curves [27].
All experiments were repeated three times.Statistical analysis
Data were expressed as the mean ± standard deviation of
three independent experiments. The statistical analyses
were performed with SPSS™ software v.10.0 (from SPSS
Inc.). Data were analyzed for statistical significance using
Dunnett’s test.
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SDS–PAGE of P. noctiluca Crude venom
Electrophoretical analysis of P. noctiluca crude venom
revealed a number of bands of varying size (Figure 1). 15
bands appeared after staining of the SDS–PAGE gel. The
molecular weights of these bands were 4; 14; 16 ; 20; 29
; 33 ; 37 ; 45 ; 55 ; 64 ; 66 ; 70 ; 80 ; 115 and 120 kDa,Figure 1 SDS-PAGE separation of P. noctiluca crude venom
proteins. Electrophoresis was carried out according to Laemmli
(1970) using 12% polyacrylamide gel.respectively. The protein components of jellyfish crude
venom were complex.
Sephadex G-75 chromatography
Proteins with molecular weights greater than 70 KDa are
completely excluded. About 200 mg of crude venom of
P. noctiluca were applied to a column packed with
Sephadex G-75 (Pharmacia, Uppsala, Sweden) at a flow
rate of 18 ml per hr gave rise to two peaks in the elution
profile monitored at 280 nm (Figure 2). The two peaks
were collected and named fraction 1 (F1) and fraction 2
(F2).
Toxicity studies
Swiss albino mice were observed during 48 h and mor-
bidity and/or mortality were recorded, for each group at
the end of observation period. The LD50 of the crude
venom was about 20 mg/kg b.w.
Analgesic activity
The inhibition percentages of writhing for P. noctiluca
crude venom and its two fractions (F1 and F2) are
shown in Table 1. The reference drug acetyl salicylate of
lysine (ASL) inhibited 61.88% of the number of writhing
elicited by acetic acid. The analgesic effect was tested
using the crude venom, F1 and F2 at the concentrations
of 1 and 2 mg/kg b.w. The administration of all tested
extracts induced a dose-dependent antinociceptive activ-
ity on Swiss albino mice. F2 possesses the highest anal-
gesic properties, at 2 mg/kg b. w. (83.15%). The crude
venom of P. noctiluca was also active; the percentage of
inhibition of writhing was 77.89% at 2 mg/kg b. w. The
lowest activity was observed with F1.
In vitro butyrylcholinesterase inhibition effect
Results of human plasma BuChE inhibitory activity of
the crude venom of P. noctiluca and its fractions are
shown in Table 2. The crude venom and its fractions
were found to inhibit the BuChE activity. The inhibition
was immediate, as evidenced by the linearity of the ab-
sorbance vs. time during the 75 s assay period
(r2> 0.978). The inhibition level of BuChE activity
increased significantly in presence of F2 compared to
the crude venom of P. noctiluca. At the highest concen-
tration (100μg/ml) of F2 and the crude venom, the in-
hibition was 68 %± 4.25 and 56.44 %± 2 respectively.
The determined IC50 were respectively 58 and 75.5 μg/
ml for F2 and the crude venom. However, F1 was the
least effective as inhibitor of enzymatic activity.
Discussion
A large number of marine organisms are known to posses
bio-active substances that have tremendous pharmaceu-
tical potential for the future [28]. However, considerable
Figure 2 Fractionation of P. noctiluca crude venom on Sephadex G-75.
Table 2 Percentage of inhibitions of
butyrylcholinesterase activity by: P. noctiluca crude









Venom 1 19.51 ± 1.20* 77.5
10 29.5 ± 1.2*
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toxic components of marine cnidarians [29-32]. Several
antimicrobial peptides have been isolated from Cnidaria
[13-16]. To our knowledge, no antimicrobial activity of P.
noctiluca venom has been reported.
Fortunately, we could obtain adequate P. noctiluca
material because of the exceptional abundance of this
jellyfish in the coastal water of Tunisia, in these recent
years. The extraction of crude venom from nematocysts
is essential before any research into crude venom tox-
icity can be conducted.
In an attempt to obtain crude venom from the nema-
tocysts of P. noctiluca, we tried some mechanical meth-
ods including sonication, which did not destroy P.
noctiluca nematocysts [33-35].
In the present study, Protein components of P. nocti-
luca nematocysts crude venom were determined by
using SDS-PAGE on 12% polyacrylamide gel. 15 distinct
clear bands were determined with molecular weight of 4;
14; 16 ; 20; 29 ; 33 ; 37 ; 45 ; 55 ; 64 ; 66 ; 70 ; 80 ; 115
and 120 kDa in P. noctiluca crude venom (Figure 1). ItTable 1 Analgesic activity of P. noctiluca crude venom, its







Control - 95±8.4 -
Venom 1 57±4.2** 40
2 21±2.8** 77.89
Fraction 1 1 35± 4.2** 63.15
2 10± 2.8** 89.47
Fraction 2 1 16± 1.4** 83.15
2 4±1.4** 95.78
Reference drug (ASL) 200 28.33± 2.06** 70.17
Values are expressed as mean ± S.E.M. (Standard Error of the Mean) (N = 6); ASL:
acetyl salicylate of lysine. Significant difference obtained with: **P< 0.01.has been reported that toxic fractions of P. noctiluca
crude venom has a molecular weight of 54, 92, 130 and
150 kDa [36].
Separation of crude crude venom of P. noctiluca was
achieved by a size exclusion chromatography (sephadex
G 75). This gel is a dextran capable of separating pro-
teins with molecular weights between 3 and 70 KDa.
The volume outside the gel matrix is known as the void
volume (Vo). This is the volume required to elute a sub-
stance so large that it cannot penetrate the pores at all.
Proteins with molecular weights greater than 70 KDa are
completely excluded. Two peaks were collected and100 56.44 ± 2*
F1 1 10.2 ± 2.5* 82
10 24 ± 4.25*
100 54.16 ± 1.5*
F2 1 12.35 ± 0.75* 58
10 32.25 ± 2.35*
100 68 ± 4.25*
(a)
Galanthamine
1 44.5 ± 1.00** 7.9
10 59.44 ± 2.5**
100 67.5 ±2.5*
Significant difference obtained with: *P< 0.05: **P< 0.01. The reported
comparisons concern: P. noctiluca crude venom versus control (a), Fraction 1
versus control (a) and Fraction 2 versus control (a). Every concentration is
compared with its equivalent in the other extract. Significant difference obtained
with: *P< 0.05: **P< 0.01.
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ities (Figure 2).
Great progress has been made in the last 30 years to-
ward understanding the neural substrates of pain and
identifying novel molecular targets for analgesic drug de-
velopment [37]. Acetic acid induced writhing method is
a sensitive procedure in detecting analgesic effect of me-
dicinal agents [38]. P. noctiluca crude venom and its
fractions (F1 and F2) showed significant analgesic action
compared to the reference drug acetyl salicylate of lysine
(ASL). The fraction 2 was found to exhibit higher anal-
gesic activity than fraction 1 against acetic acid induced
pain in mice at two dose levels (1 & 2 mg/kg b.w.), these
doses were not toxic for mice.
Suganthi et al [17] reported that intraperitoneally ad-
ministration of 200 mg/kg of Crambionella stuhalmanni
and Chrysaora quinquecirrha extracts significantly in-
hibit acetic acid induced writhing in mice, the inhibition
of writhing response and central nervous system depres-
sing activity percentage were 35%, 55% and 90%, 95%.
The present results coincide with those reported by
other authors who studied the analgesic property of
Conus lentiginosus and C. mutabilis, which was 128
times more than that of paracetamol [39]. Shanmuga-
nandam [40] reported the effectiveness of Conus figuli-
nus venom on guinea pig skin as an infiltration
anaesthetic agent. Salivary gland secretion of the
gastropod Conus sp. is one of the most important
venoms to possess analgesic property [41,42].
It is, therefore, assumed that central mechanisms may
be involved in the observed phenomenon since the ex-
tract could elicit activities against pain model. Agents
that exhibit these activities are believed to act primarily
on the central nervous system.
Stomolophus nomurai stings produce distinctive psy-
chiatric signs and symptoms [43,44]. The brain oper-
ation experiments show that this organ can be affected
by the venom of Chrysaora quinquecirrha. The biphasic
action, an early disorientation followed by recovery then
eventual death may indicate two separate neuro-active
principles in the venom [45].
Neurotoxins are components of venoms that are spe-
cifically directed against the nervous system. The mo-
lecular variety of these substances extends from low
molecular weight alkaloids to peptides and complex pro-
teins [46]. In Cnidaria the neurotoxins have been the
subject of numerous studies [11,12,47]. Sanchez-
Rodriguez et al [48] isolated a 120-kDa protein from the
cubomedusa Carybdea marsupialis with a strong neuro-
toxic activity on marine crabs (Ocypode quadrata).
The principal role of cholinesterase (ChE) is the ter-
mination of nerve impulse transmission at the choliner-
gic synapses by rapid hydrolysis of acetylcholine (ACh).
Inhibition of ChE serves as a strategy for the treatmentof Alzheimer’s disease (AD), senile dementia, ataxia, my-
asthenia gravis and Parkinson’s disease [49,50].
In this study, the crude venom of P. noctiluca and its
fractions (F1and F2) were tested to determine their abil-
ity as human BuChE inhibitors. The BuChE inhibition
was determined using an adaptation of the method
described by Ellman et al [25]. P. noctiluca crude venom,
F 1 and F 2 exhibited moderate to good anti-BuChE ac-
tivity. In fact, the best inhibitory activity was determined
by the F 2, with an order of inhibition capacity: F2>
crude venom> F1.
In spite of the widespread occurrence of AChE in ani-
mals only a few AChE inhibitors from natural sources
have been isolated. For example, polypeptide fasciculins
from mamba venom [50] and an alkaloids such as
physostigmine from ordeal or Calabar bean [51]. An
ethanolic extract from a zoanthid crust coral Para-
zoanthus axinellae exhibited anticholinesterase activity
[52].
The present study indicated that jellyfish P. noctiluca
crude venom and its fractions contained peptides with
specific cholinesterase inhibitory activities which might
be responsible for some of the neurotoxic effects of the
venom on animals and humans.
Conclusions
In summary, we have shown for the first time that P.
noctiluca crude venom and its fractions displayed anal-
gesic and anti-BuChE activities at different doses with-
out inducing acute toxicity. In the light of the obtained
results, P. noctiluca crude venom can be considered as
an effective agent to treat pain and neurodegenerative
disorders such as AD. In future experiments, studies
with purified fractions of P. noctiluca venom peptides
could be conducted for further pharmacological, bio-
logical and toxicological characterization, such as the re-
search of the antibiotic properties.
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